Cardiac Infections
Infective endocarditis
Background
Infective endocarditis (IE) can present with various clinical features, depending on intracardiac pathology, evolution of the infection and possible extra-cardiac involvement. In general, a fever and a new murmur indicate endocarditis until proven otherwise.
Clinical presentation
General features of infection include malaise, anorexia, weight loss and night sweats. Anaemia, clubbing and splenomegaly can occur in long standing infections. Cardiac manifestations of infection include congestive cardiac failure, palpitations, tachycardia, a new murmur and AV block.
In addition, patients may present with haemorrhagic manifestations. For instance, on the skin you may see petechiae, splinter haemorrhages, and small tender nodules on palms and soles of feet; pulp infarcts known as Osler’s nodes.
In the eye, you may see oval shaped retinal haemorrhages with a pale centre located near the optic disc, these are known as Roth spots. Conjunctival splinter haemorrhages and retinal flame haemorrhages may also be seen.
In the kidney, microscopic haematuria may be seen, with glomerulonephritis as a result of immune complex deposition. Cerebrally, you may also have toxic encephalopathy.
Diagnosis & Treatment
2 Major or 1 Major and 3 Minor criteria are required, or all 5 minor criteria are required.
| Major criteria |
|---|
| Positive blood cultures for IE (1 of the following): |
| Typical microorganisms consistent with IE from 2 separate blood cultures |
| Persistently positive blood culture |
| For organisms that are typical causes of IE – At least 2 positive blood cultures from blood samples drawn >12 hours apart |
| For organisms that are more commonly skin contaminants – 3 or a majority of ≥4 separate blood cultures (with first and last drawn at least 1 hour apart) |
| Single positive blood culture for Coxiella burnetii or phase I IgG antibody titre >1:800 |
| Evidence of endocardial involvement (1 of the following): |
| Echocardiogram positive for IE: |
| Vegetation (oscillating intracardiac mass on a valve or on supporting structures, in the path of regurgitant jets, or on implanted material, in the absence of an alternative anatomic explanation), OR |
| Abscess, OR |
| New partial dehiscence of prosthetic valve |
| New valvular regurgitation |
| NB – Increase in or change in pre-existing murmur not sufficient |
| Minor criteria |
| Predisposition – Intravenous drug use or presence of a predisposing heart condition (prosthetic heart valve or a valve lesion associated with significant regurgitation or turbulence of blood flow) |
| Fever – Temperature ≥38.0°C (100.4°F) |
| Vascular phenomena – Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial haemorrhage, conjunctival haemorrhages, or Janeway lesions |
| Immunologic phenomena – Glomerulonephritis, Osler nodes, Roth spots, or rheumatoid factor |
| Microbiological evidence – Positive blood cultures that do not meet major criteria OR serologic evidence of active infection with organism consistent with IE |
Medical treatment is based on the sensitivity of organisms isolated, with broad spectrum antibiotics used in the initial blind therapy when infective endocarditis is suspected. Surgery also plays a significant role in the management of IE, this will be teased out in the following questions.
Prophylaxis
Antibiotic Prophylaxis for IE is suggested only in the setting of conditions associated with the highest risk of an adverse outcome if IE occurs. For instance, patients with prosthetic valves or valve repairs using devices such as annuloplasty, rings or clips should have prophylaxis. In addition, those with left ventricular assist devices or previous or recurrent IE should also have prophylaxis.
In patients with a history of congenital heart disease, it can become more complex. Prophylaxis is indicated in those with unrepaired cyanotic heart disease and those with defects that have been fully or partially fixed with prosthetic materials.
References
- Chu VH, Calderwood SB, Baron EL. Native valve endocarditis: Epidemiology, risk factors, and microbiology. In UpToDate, Calderwood SB (Ed), UpToDate, Waltham, MA. (Accessed May 2022)
- Ramrakha PS, Moore KP, Sam A. Oxford Handbook of Acute Medicine (3rd ed.). Oxford (UK): Oxford University Press; 2010
- Wilkinson IE, Raine T, Wiles K, Goodhart A, Hall C, O’Neill H. Oxford Handbook of Clinical Medicine (10th ed.). Oxford (UK): Oxford University Press; 2017
- Karchmer AF, Calderwood SB, Baron EL. Prosthetic valve endocarditis: Epidemiology, clinical manifestations, and diagnosis. In UpToDate, Calderwood SB (Ed), UpToDate, Waltham, MA. (Accessed May 2022)
- Wang A, Bolger A, Yeon SB. Overview of management of infective endocarditis in adults. In UpToDate, Calderwood SB (Ed), UpToDate, Waltham, MA. (Accessed May 2022)
- Sexton DJ, Calderwood SB, Baron EL. Right-sided native valve infective endocarditis. In UpToDate, Calderwood SB (Ed), UpToDate, Waltham, MA. (Accessed May 2022)
- Sexton DJ, Otto CM, Baron EL. Antimicrobial prophylaxis for the prevention of bacterial endocarditis. In UpToDate, Calderwood SB (Ed), UpToDate, Waltham, MA. (Accessed May 2022)
Rheumatic fever
Rheumatic fever occurs as a result of autoimmune phenomena 2-4 weeks after group A streptococcal infection.
Diagnosis
Diagnosis is based on the revised Jones criteria. This entails evidence of recent streptococcal infection as well as 2 major criteria, or 1 major and 2 minor.
| Major criteria |
|---|
| Evidence of recent streptococcal infection (1 of the following): |
| Positive throat culture for group A beta-haemolytic streptococci |
| Positive rapid streptococcal antigen test |
| Elevated or rising antistreptococcal antibody titre – Either Anti-Streptolysin O (ASO) or Anti-Deoxyribonuclease B (ADB) |
| Evidence of Major criteria (1 of the following): |
| Arthritis – usually migratory polyarthritis involving large joints |
| Carditis or Valvulitis (i.e. pancarditis), this can be clinical or subclinical |
| CNS involvement (e.g. Sydenham’s chorea) |
| Subcutaneous nodules |
| Erythema marginatum |
| Minor Criteria |
| Arthralgia |
| Fever |
| Elevated acute phase reactants (ESR or CRP) |
| Prolonged PR interval on ECG |
Treatment
This is based on eradication of GAS, often IM penicillin G is used. Thereafter, treatment is supportive, with prophylaxis against future infection.
References
- Wilkinson IE, Raine T, Wiles K, Goodhart A, Hall C, O’Neill H. Oxford Handbook of Clinical Medicine (10th ed.). Oxford (UK): Oxford University Press; 2017
- Steer A, Sundel R, TePas E. AF, Calderwood SB, Baron EL. Acute rheumatic fever: Clinical manifestations, diagnosis, treatment and prevention. In UpToDate, TePas E (Ed), UpToDate, Waltham, MA. (Accessed May 2022)
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.